Literature DB >> 29314270

Association of leptin with disease severity and inflammation indicators in Chinese obese children with allergic rhinitis.

Wenlong Liu1, Qingxiang Zeng1, Lifeng Zhou1, Renzhong Luo1, Haipeng Dong2.   

Abstract

BACKGROUND: The prevalence of both obesity and allergic diseases in children has increased over the last several decades. However, the direct relationship between diverse allergic diseases and obesity has varied in different studies. Therefore, we aimed to examine the effect of obesity on the incidence and severity of allergic rhinitis (AR) and the possible key inflammation mediators during AR.
METHODS: A total of 3126 healthy students (without chronic diseases) were recruited from 14 randomly selected secondary schools in Guangzhou, China. Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHR), and body fat percentage (PBF) were measured and compared. The effect of obesity indicators and leptin level (exposures) on the incidence (primary outcome) and severity of AR (secondary outcomes) was analyzed. Inflammatory markers were detected and compared among groups.
RESULTS: The symptom score (9.5 ± 3.1 vs 8.2 ± 3.5, P < .05) and medication score (3.6 ± 1.6 vs 2.9 ± 1.8, P < .05) were significantly higher in obese children with AR than in non-obese children with AR. After adjusting for potential confounders, multiple linear regression analysis showed that the serum leptin concentration was significantly correlated with the levels of T-helper (TH) 2 cytokines (coefficient, 0.48 [95% CI, 0.05-0.91]), TH17 cytokines (coefficient, 0.39 [95% CI, 0.11-0.89]), and regulatory T-cell cytokines (IL-10, coefficient, -0.43 [95% CI, -0.02-0.65]; TGF-β, coefficient, -0.65 [95% CI, -0.06-1.35]) in patients with AR.
CONCLUSIONS: Our study shows that obesity exacerbates inflammation and contributes to disease severity in AR. Our study provides evidence that leptin was involved in enhanced TH inflammation as well as the accumulation and activation of inflammatory cells in obese children with AR.
© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  allergic rhinitis; children; leptin; obesity

Mesh:

Substances:

Year:  2018        PMID: 29314270     DOI: 10.1111/pai.12856

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  6 in total

1.  Identification of contributing predictors for short stature and pre-shortness among 7310 Chinese preschool-aged children.

Authors:  Yuan Yuan; Bo Zhou; Kundi Wang; Yunfeng Wang; Zhixin Zhang; Wenquan Niu
Journal:  Endocrine       Date:  2020-10-27       Impact factor: 3.633

Review 2.  Role of Obesity in Otorhinolaryngologic Diseases.

Authors:  Su Young Jung; Dong Choon Park; Sang Hoon Kim; Seung Geun Yeo
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-03       Impact factor: 4.806

3.  MicroRNA-375-mediated regulation of ILC2 cells through TSLP in allergic rhinitis.

Authors:  Xi Luo; Qingxiang Zeng; Shengbao Yan; Wenlong Liu; Renzhong Luo
Journal:  World Allergy Organ J       Date:  2020-08-09       Impact factor: 4.084

4.  Leptin/Osteopontin Axis Regulated Type 2T Helper Cell Response in Allergic Rhinitis with Obesity.

Authors:  Qingxiang Zeng; Xi Luo; Miaomiao Han; Wenlong Liu; Huabin Li
Journal:  EBioMedicine       Date:  2018-06-07       Impact factor: 8.143

5.  Smoking behavior might affect allergic rhinitis and vasomotor rhinitis differently: A mendelian randomization appraisal.

Authors:  Sai Wang; Li Qi; Hongquan Wei; Feifei Jiang; Aihui Yan
Journal:  World Allergy Organ J       Date:  2022-02-05       Impact factor: 4.084

6.  Obesity and childhood asthma in male schoolchildren in Saudi Arabia: Is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21?

Authors:  Mohammed Al-Ayed; Khalid Alshaybari; Dhafer Alshehri; Alzahrani Jamaan; Iman Nasser; Hamdan Alaamri; Wed Alaseeri; Ahmed A Mahfouz; Saeed Ali Alsareli; Ahmed Morad Asaad; Aamir Ali Magzoub; Mohamed Ansar Qureshi; Mohammed Helmy Shalayel
Journal:  Ann Saudi Med       Date:  2019-10-03       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.